Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-19

Clinical Trial Update: Pegasys VR: Integrating Virtual Humans in the Treatment of Child Social Anxiety [Phase 2]

View source ↗

Summary

Phase 2 trial assessing Pegasys VR for treating child social anxiety disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pegasys VR (not specified)

Snippet

Sponsor: University of Central Florida | Conditions: Anxiety Disorders | Phase 2 | Status: COMPLETED